Xiao Dong

2.7k total citations · 1 hit paper
55 papers, 2.2k citations indexed

About

Xiao Dong is a scholar working on Molecular Biology, Cancer Research and Biomedical Engineering. According to data from OpenAlex, Xiao Dong has authored 55 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 19 papers in Cancer Research and 18 papers in Biomedical Engineering. Recurrent topics in Xiao Dong's work include Nanoplatforms for cancer theranostics (17 papers), Nanoparticle-Based Drug Delivery (13 papers) and Cancer-related molecular mechanisms research (12 papers). Xiao Dong is often cited by papers focused on Nanoplatforms for cancer theranostics (17 papers), Nanoparticle-Based Drug Delivery (13 papers) and Cancer-related molecular mechanisms research (12 papers). Xiao Dong collaborates with scholars based in China, Singapore and United States. Xiao Dong's co-authors include Shao Q. Yao, Xian‐Zheng Zhang, Chao Fang, Qin Lu, Hongzhuan Chen, Jonathan F. Lovell, Si‐Cong Yang, Ren‐Xi Zhuo, Xing Lai and Hai‐Yi Feng and has published in prestigious journals such as Advanced Materials, Angewandte Chemie International Edition and SHILAP Revista de lepidopterología.

In The Last Decade

Xiao Dong

53 papers receiving 2.2k citations

Hit Papers

Mito‐Bomb: Targeting Mitochondria for Cancer Therapy 2021 2026 2022 2024 2021 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiao Dong China 23 1.2k 945 811 553 326 55 2.2k
Seunglee Kwon South Korea 21 1.3k 1.1× 902 1.0× 1.1k 1.3× 613 1.1× 202 0.6× 29 2.7k
Hyewon Ko South Korea 24 1.4k 1.2× 684 0.7× 1.0k 1.2× 532 1.0× 163 0.5× 36 2.3k
Ziyang Cao China 29 1.1k 0.9× 919 1.0× 519 0.6× 398 0.7× 216 0.7× 64 2.3k
Haotian Zhang China 21 1.4k 1.1× 716 0.8× 914 1.1× 395 0.7× 139 0.4× 46 2.0k
Sheng Hong China 24 1.2k 0.9× 865 0.9× 715 0.9× 476 0.9× 137 0.4× 43 2.5k
Xiongwei Deng China 24 912 0.7× 877 0.9× 626 0.8× 358 0.6× 359 1.1× 56 1.9k
Wooram Um South Korea 28 1.9k 1.5× 1.0k 1.1× 1.0k 1.3× 680 1.2× 276 0.8× 61 3.2k
Xiao Fu China 22 1.4k 1.1× 873 0.9× 791 1.0× 765 1.4× 143 0.4× 60 2.6k
Shuang Dou China 20 848 0.7× 1.3k 1.4× 1.1k 1.3× 293 0.5× 245 0.8× 32 2.5k
Tzu‐yin Lin United States 26 1.3k 1.0× 748 0.8× 682 0.8× 643 1.2× 136 0.4× 80 2.4k

Countries citing papers authored by Xiao Dong

Since Specialization
Citations

This map shows the geographic impact of Xiao Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiao Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiao Dong more than expected).

Fields of papers citing papers by Xiao Dong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiao Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiao Dong. The network helps show where Xiao Dong may publish in the future.

Co-authorship network of co-authors of Xiao Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Xiao Dong. A scholar is included among the top collaborators of Xiao Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiao Dong. Xiao Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Du, Wei, Shubo Du, Xiao Dong, et al.. (2023). Biodegradable silica nanocapsules enable efficient nuclear-targeted delivery of native proteins for cancer therapy. Biomaterials. 294. 122000–122000. 35 indexed citations
3.
Dong, Xiao, Shubo Du, Mao‐Hua Zhu, et al.. (2023). Tumor Metabolism-Rewriting Nanomedicines for Cancer Immunotherapy. ACS Central Science. 9(10). 1864–1893. 25 indexed citations
4.
Yuan, Peiyan, Fen Yang, Si Si Liew, et al.. (2022). Intracellular Co-delivery of native antibody and siRNA for combination therapy by using biodegradable silica nanocapsules. Biomaterials. 281. 121376–121376. 26 indexed citations
5.
Dong, Xiao, Rajeev Kungur Brahma, Chao Fang, & Shao Q. Yao. (2022). Stimulus-responsive self-assembled prodrugs in cancer therapy. Chemical Science. 13(15). 4239–4269. 100 indexed citations
6.
Dong, Xiao, Wenqiang Chen, Shubo Du, et al.. (2021). Broad-Spectrum Polymeric Nanoquencher as an Efficient Fluorescence Sensing Platform for Biomolecular Detection. ACS Sensors. 6(8). 3102–3111. 12 indexed citations
7.
Dong, Xiao, et al.. (2021). Recent Advances in Polymeric Nanoparticles for Enhanced Fluorescence and Photoacoustic Imaging. Angewandte Chemie. 133(33). 17941–17953. 1 indexed citations
8.
Xiao, Qicai, Xiao Dong, Fen Yang, et al.. (2021). Engineered Cell‐Penetrating Peptides for Mitochondrion‐Targeted Drug Delivery in Cancer Therapy. Chemistry - A European Journal. 27(59). 14721–14729. 26 indexed citations
9.
Dong, Xiao, et al.. (2021). Live-Cell Imaging of Survivin mRNA by Using a Dual-Color Surface-Cross-Linked Nanoquencher. Analytical Chemistry. 93(35). 12081–12089. 8 indexed citations
10.
Xiao, Qicai, Wei Du, Xiao Dong, et al.. (2021). Cell‐Penetrating Mitochondrion‐Targeting Ligands for the Universal Delivery of Small Molecules, Proteins and Nanomaterials. Chemistry - A European Journal. 27(47). 12207–12214. 11 indexed citations
11.
Dong, Xiao, et al.. (2021). Recent Advances in Polymeric Nanoparticles for Enhanced Fluorescence and Photoacoustic Imaging. Angewandte Chemie International Edition. 60(33). 17797–17809. 91 indexed citations
12.
Dong, Xiao, Si‐Cong Yang, Xing Lai, et al.. (2021). Targeted Cancer Chemophototherapy: Biomimetic Liposomal Nanoplatinum for Targeted Cancer Chemophototherapy (Adv. Sci. 8/2021). Advanced Science. 8(8). 2 indexed citations
13.
Zhang, Xiaotong, Wei Zhao, Xiao Dong, et al.. (2021). Long non-coding RNA LINC02446 suppresses the proliferation and metastasis of bladder cancer cells by binding with EIF3G and regulating the mTOR signalling pathway. Cancer Gene Therapy. 28(12). 1376–1389. 16 indexed citations
14.
Chen, Zhongjian, Si‐Cong Yang, Xueliang Liu, et al.. (2020). Nanobowl-Supported Liposomes Improve Drug Loading and Delivery. Nano Letters. 20(6). 4177–4187. 104 indexed citations
15.
Dong, Xiao, Lili Mu, Si‐Cong Yang, et al.. (2020). Biomimetic, Hypoxia‐Responsive Nanoparticles Overcome Residual Chemoresistant Leukemic Cells with Co‐Targeting of Therapy‐Induced Bone Marrow Niches. Advanced Functional Materials. 30(12). 43 indexed citations
16.
Dong, Xiao, Haijun Liu, Hai‐Yi Feng, et al.. (2019). Enhanced Drug Delivery by Nanoscale Integration of a Nitric Oxide Donor To Induce Tumor Collagen Depletion. Nano Letters. 19(2). 997–1008. 200 indexed citations
17.
Dong, Xiao, et al.. (2019). <p>Exosomes-Derived Long Non-Coding RNA HOTAIR Reduces Laryngeal Cancer Radiosensitivity by Regulating microRNA-454-3p/E2F2 Axis</p>. OncoTargets and Therapy. Volume 12. 10827–10839. 22 indexed citations
18.
Wang, Weiwei, Xiangyun Li, Zhaohong Wang, et al.. (2018). A novel “mosaic-type” nanoparticle for selective drug release targeting hypoxic cancer cells. Nanoscale. 11(5). 2211–2222. 21 indexed citations
19.
Dong, Xiao, Jingjing Hu, Jingyi Zhu, et al.. (2016). A redox-responsive mesoporous silica nanoparticle with a therapeutic peptide shell for tumor targeting synergistic therapy. Nanoscale. 8(37). 16702–16709. 50 indexed citations
20.
Luan, Xin, Ying‐Yun Guan, Jonathan F. Lovell, et al.. (2016). Tumor priming using metronomic chemotherapy with neovasculature-targeted, nanoparticulate paclitaxel. Biomaterials. 95. 60–73. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026